In April of 2013, construction of NKY’s new plant with 138,800 m2of land and 50,000 m2of structure was completed, making it the production center for our PVP and PVM/MA polymer families. The new facilities includes production capacity of: 12,000 tons/year GBL; 5,000 tons/year 2-pyrrolidone; 5,000 tons/year NVP; 2,500 tons/year PVM/MA copolymer; 2,000 tons/year MVE and 5,000 tons/year PVP’s.
Our product offerings include: GBL, 2-P, NVP monomer, PVP K series, Copovidone, VP/VA copolymer series, PVPP, PVP-I complex, vinyl ether intermediate and PVM/MA copolymers. NKY is the only domestic company capable of manufacturing PVP K-12 (powder and liquid) and PVP K-60, K-90 and K-120 powders.
All pharmaceutical, cosmetic, food and oral care products are manufactured according to cGMP regulations in our new facilities, making it a model for China’s excipient and food additive’s production safety management.
With the establishment of the R&D Center in Boai and the Technical Research Center in Tianjin, NKY is committed to R&D and the development of new products and technologies to bring new solutions and value to their customers. We are continuously striving to become the most trusted partner to our customers by providing materials that meet their quality requirements and enhance their finished product’s performance.
The company continues to develop new technologies and capabilities to better serve its market as can be attested by the many company patents and distinctions. Recently, NKY has been awarded the distinction as National Torch Plan high-tech company, qualifying the company as a State-level high-tech enterprise. On a provincial level, our technical R&D center has been qualified as a Jiaozuo innovation center and our company as an environmentally responsible enterprise.
We provide high
quality pharmaceutical excipients for our customers in more than 60 countries worldwide.
Boai NKY has formally registered on REACH for PVP/Monomer NVP (upto 1000MT/a), Register No.: 01-2119498301-39-0002
NKY®is the registered trademark of Boai NKY Pharmaceuticals Ltd (NKY). KoVidone®, PolyKoVidone®, PolyFilter®, PolyViscol®, WhiVidone®, OraRez®are the trademark names of NKY.
KoVidone® as binder, solubilizer, dispersant & coating agent; PolyKoVidone® as super disintegrant.
NKY® PVP series for water treatment, glue sticks, inks, membrane, textile, oil recovery, glass fiber etc.
OraRez® series for denture adhesive, mouthwash, toothpaste.
PolyViscol® series for hair-styling & skin care as film-former, thinkening agent.
PolyFilter® as stabilizer for beer, wine and beverages.
NKY® N-Vinyl Pyrrolidone(NVP), 2-Pyrrolidone(2-P), and Vinyl Ethers.
In-Cosmetics Global 2019 was held in Paris on April, 2nd, 2019.Focus more on customer service and product innovationA new R&D centre with occupied area of 6200 ㎡ has been put into operation at headquarter of Boai NKY which is located in jiaozuo, China. By using most advanced synthesis, process and analytical equipment, the new R&D centre will highly improve our new product development and customer service capabilities.A full set of pilot manufacturing facility with capacity of 1-1,000Kg will co-work with the new R&D centre to make our internal operations more active. And it's also open to our customers for new-product development and marketing.With sustained effort on product research and development, three new products have been launched into personal care market.PiloRez hs-564: A kind of new polymer used in hair styling product. With performance of high gloss, strong adhesion & good toughness.DermaRez Protect 216 and 220: Effective waterproof agent, film forming agent & dispersant. Suitable for production of sun-protection and makeup products.Boai NKY is committed to provide high-quality products to our customers. We have been working on exploring and introducing new technology to promote our production capacity, quality management ability, as well as R&D capability. Our competitive technical team, continuous improved quality management system and perfect after-sales service have earned us customer's trust in our products.Read more<<
The annual product-promotion tour of Boai NKY Pharmaceuticals Ltd. was successfully held in Malaysia & Indonesia between March, 25th~28th, 2019.Conference photograph of Boai NKY staff, conference sponsor (Narda Tita) & customer representatives-took in Indonesia.Dr. Herbert Ulmer (fifth from right), chief scientist of Boai NKY. Mr. Wojciech Bobecki (fourth from right), deputy GM of Boai NKY-Germany branch. Mr. Wang long (third from right), GM assistant of Tianjin Boai NKY international ltd., and staffs from Narda Tita.The product-promotion tour is a clear sign which shows that Boai NKY is stepping into market of Southeast Asia. We are going to focus more on customer service & technical support. Expecting to futhering cooperation with our customers on technical communication & collaborative R&D.The product-promotion tour brought our customers a deep understanding on competence of Boai NKY & quality of our products. They are looking forward to connecting with our engineers for customized solutions.Dr Herbert Ulmer, chief scientist of Boai NKY.Mr. Wang longNot only can providing high quality pharmaceutical excipients, Boai NKY also be willing to technically support our customers on regulations, supply chains, environmental protection & prodcut formula. A full set of pharmaceutical-excipients solution is what we are committed to offer.Read more<<
On the afternoon of April 6, 2019, a delegation of 19 guests from California state administration of politics and business attended the henan international investment fair, led by Mayor Pro Tem Samuel Kang (City of Duarte, CA), visited the new open source boai factory.Group photo of guestsIn this sunny afternoon on Saturday, the new open source group vice chairman Mr Jian wang strong greeted all the guests, and to introduce the guests to the company's development history and the current in functional polymer materials and precise medical service of the double main business development situation, emphasizes the new open source is an international business enterprises, and through the acquisition of biological reagents BioVision (March 2018), and high-throughput gene sequencing and the depth of the world leading enterprise Illumina cooperation, has established extensive cooperation with the California,In order to broaden the medical research and clinical diagnosis and treatment of both companies in the application of technology has created a broad prospect.Vice chairman wang through the new open source polymer materials exports the United States are also imposed a special 25% tariff (two kinds of material are the special duties included in the product List 2) suffered unfair treatment, for example, that China and the United States are "and while confrontation, war two defeats" relationship, hope to visit the government officials, entrepreneurs, pay full attention to and exert their influence, make is approaching the end of the two countries business negotiations as soon as possible the trump the President expressed by eventually withdraw their special tariff measures on both sides.Attend the visit Kang Guchen mayor, and California Huron, mayor of Rey Mr Leon and Merced County sheriff Luo Jige - ace Mr Pinault and (Supervisor Mr. Rodrigo Espinoza, Merced County, CA) vice chairman proposal to give to the king the enthusiastic response, have expressed hope that the peaceful end as soon as possible trade war has come, says this is one of their important purpose of the visit, hope we can understand their thoughts - between China and the United States should be friends instead of enemies. Vice chairman wang jianqiang was introducing the company's development to the guestsMs. Carmen Montano, city councillor of Milpitas, poses for a photo with Mr. Wang jianqiangThe guests to the new open source of the concept of green industrial development, and is being put into practice in many clean energy action is highly appreciated and energy-saving environmental protection efforts, at the same time listen to the layout of a company in the aspect of precision medical and effort, new open source in the future will be more new technology applied in the clinical medicine of medical detection had hope.New open source acquisition to the headquarters of the Milpitas, California, senator BioVision Carmen Montano, ms learned that we have investment in her city, feel special surprise and excitement, though this is her first trip to China, but the development of China in fact beyond her imagination, hope in the future do what she can to promote the communication between China and the United States enterprises.Leaders from henan provincial government, jiaozuo municipal government and boai county government attended the meeting.Read more<<